MedTrace Logo

Randomized Controlled Trial of Treatment of Male Partners of Women With BV

NCT02209519 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 214

Last updated 2020-04-27

Study results available
· View outcomes & findings →

Summary

Male partners of womoen with recurrent bacteria vaginosis are randomized to treatment with metronidazole or placebo to compare the rates of recurrent BV in the women

Conditions

  • Recurrent Bacterial Vaginosis

Interventions

DRUG

Metronidazole (male partner)

500 mg PO BID for 7 days

OTHER

Placeob (male partner)

matching placebo capsules PO BID for 7 days

Sponsors & Collaborators

  • Wayne State University

    collaborator OTHER

  • University of Alabama at Birmingham

    lead OTHER

Principal Investigators

  • jane Schwebke, MD · University of Alabama at Birmingham

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
QUADRUPLE
Model
SINGLE_GROUP

Eligibility

Min Age
19 Years
Max Age
50 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-02-28
Primary Completion
2019-03-31
Completion
2019-03-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02209519 on ClinicalTrials.gov